OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
Source: Decrypt ·
The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.
Read the full story at Decrypt
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.